<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus of the Diagonal Band - Vertical Limb</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000560](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000560)</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Memory/learning</td>
</tr>
<tr>
<td class="label">Entorhinal cortex</td>
<td>Sensory integration</td>
</tr>
<tr>
<td class="label">Olfactory bulb</td>
<td>Olfactory processing</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">ChAT</td>
<td>Acetylcholine synthesis</td>
</tr>
<tr>
<td class="label">AChE</td>
<td>Acetylcholinesterase</td>
</tr>
<tr>
<td class="label">p75NTR</td>
<td>Low-affinity NGF receptor</td>
</tr>
<tr>
<td class="label">VAChT</td>
<td>Vesicular ACh transporter</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CHAT</td>
<td>Acetylcholine synthesis</td>
</tr>
<tr>
<td class="label">AChE</td>
<td>Acetylcholine hydrolysis</td>
</tr>
<tr>
<td class="label">AChE</td>
<td>Acetylcholinesterase</td>
</tr>
<tr>
<td cl
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus of the Diagonal Band - Vertical Limb</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000560](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000560)</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Memory/learning</td>
</tr>
<tr>
<td class="label">Entorhinal cortex</td>
<td>Sensory integration</td>
</tr>
<tr>
<td class="label">Olfactory bulb</td>
<td>Olfactory processing</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">ChAT</td>
<td>Acetylcholine synthesis</td>
</tr>
<tr>
<td class="label">AChE</td>
<td>Acetylcholinesterase</td>
</tr>
<tr>
<td class="label">p75NTR</td>
<td>Low-affinity NGF receptor</td>
</tr>
<tr>
<td class="label">VAChT</td>
<td>Vesicular ACh transporter</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CHAT</td>
<td>Acetylcholine synthesis</td>
</tr>
<tr>
<td class="label">AChE</td>
<td>Acetylcholine hydrolysis</td>
</tr>
<tr>
<td class="label">AChE</td>
<td>Acetylcholinesterase</td>
</tr>
<tr>
<td class="label">NGF</td>
<td>Nerve growth factor</td>
</tr>
<tr>
<td class="label">BDNF</td>
<td>Brain-derived neurotrophic factor</td>
</tr>
<tr>
<td class="label">p75NTR</td>
<td>NGF receptor (NTRK1)</td>
</tr>
<tr>
<td class="label">TrkA</td>
<td>Tropomyosin receptor kinase A</td>
</tr>
<tr>
<td class="label">VAChT</td>
<td>Vesicular ACh transporter</td>
</tr>
<tr>
<td class="label">CHRNA4</td>
<td>Nicotinic receptor α4 subunit</td>
</tr>
<tr>
<td class="label">CHRNA7</td>
<td>Nicotinic receptor α7 subunit</td>
</tr>
<tr>
<td class="label">M1R (CHRM1)</td>
<td>Muscarinic receptor M1</td>
</tr>
<tr>
<td class="label">APP</td>
<td>Amyloid precursor protein</td>
</tr>
<tr>
<td class="label">MAPT</td>
<td>Tau protein</td>
</tr>
<tr>
<td class="label">Pathology</td>
<td>Effect on VDB</td>
</tr>
<tr>
<td class="label">Cholinergic neuron loss</td>
<td>50-70% reduction in ChAT activity</td>
</tr>
<tr>
<td class="label">Amyloid-β deposition</td>
<td>Direct toxicity to cholinergic neurons</td>
</tr>
<tr>
<td class="label">Neurofibrillary tangles</td>
<td>Tau pathology in surviving neurons</td>
</tr>
<tr>
<td class="label">Reduced NGF transport</td>
<td>Impaired trophic support</td>
</tr>
<tr>
<td class="label">Cortical denervation</td>
<td>Loss of hippocampal projections</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>VDB Involvement</td>
</tr>
<tr>
<td class="label">Vascular dementia</td>
<td>Ischemic damage to cholinergic projections</td>
</tr>
<tr>
<td class="label">FTD</td>
<td>Frontal cholinergic dysfunction</td>
</tr>
<tr>
<td class="label">DLB</td>
<td>Cortical cholinergic deficits</td>
</tr>
<tr>
<td class="label">MS</td>
<td>Cholinergic pathway demyelination</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">NGF gene therapy</td>
<td>Restore trophic support</td>
</tr>
<tr>
<td class="label">Cholinergic stem cell transplants</td>
<td>Replace lost neurons</td>
</tr>
<tr>
<td class="label">p75NTR modulators</td>
<td>Enhance NGF signaling</td>
</tr>
<tr>
<td class="label">Anti-amyloid immunotherapies</td>
<td>Reduce Aβ toxicity</td>
</tr>
</table>
Nucleus Of The Diagonal Band Vertical Limb is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The vertical limb of the diagonal band of Broca (VDB) is part of the basal forebrain cholinergic system. It projects to the hippocampus and olfactory bulb and is crucial for memory, attention, and cortical arousal. [@yang2018]
<!-- multi-taxonomy-enrichment -->
The VDB is located at the base of the forebrain, medial to the olfactory tubercle and ventral to the anterior commissure. [@liu2015]
The study of Nucleus Of The Diagonal Band Vertical Limb has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The vertical limb of the diagonal band (VDB) contains cholinergic neurons that utilize acetylcholine as their primary neurotransmitter. These neurons exhibit several key molecular characteristics:
The nucleus of the diagonal band is severely affected in Alzheimer's disease:
The VDB is a primary target for acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) which compensate for reduced cholinergic transmission [@birks2006].
In Parkinson's disease, the VDB exhibits:
[@mesulam2004]: [Mesulam et al. (2004): Diagonal band cholinergic system](https://pubmed.ncbi.nlm.nih.gov/14742686/)
[@yang2018]: [Yang et al. (2018): VDB and memory](https://pubmed.ncbi.nlm.nih.gov/29486423/)
[@liu2015]: [Liu et al. (2015): Cholinergic deficits in PD](https://pubmed.ncbi.nlm.nih.gov/25882656/)
The following diagram shows the key molecular relationships involving Nucleus of the Diagonal Band - Vertical Limb discovered through SciDEX knowledge graph analysis: